Skip to content

Illinois · Nonprofit

SICK CELLS

SICK CELLS (Illinois) receives grants from 5 organizations whose IRS filings report $206,520 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($95,500). 4 of them have funded it in more than one year.

Revenue FY2025
$1.1M
Funders on record
5
Grants received
$207k
Net assets
$280k
4/5 repeat funderspeak grant-dependency 13%
01What it does

What Sick Cells does

Mission

Sick Cells is a national advocacy nonprofit for sickle cell disease (scd). Originally a documentary project started in 2008, Sick Cells grew to much more and was founded as a 501c3 nonprofit in 2017. Sick Cells' mission is to elevate the voices of the scd community and our stories of resilience. In highlighting the grave disparities our community faces, we will influence decision-makers and propel change.

As stated on its FY2025 Form 990.

Program

  1. In 2025, our organization conducted a wide range of education and outreach activities aimed at increasing awareness and understanding of sickle cell disease (scd), while also working to improve access to care for individuals living with the condition. We hosted two national events-the 2025 scd policy forum and the 2025 Sick Cells therapeutics conference-which engaged over 484 participants, including patients, caregivers, researchers, medicaid directors, healthcare providers, commercial payers, and other key stakeholders.our programs advanced our mission to improve quality of life for people with scd through public policy advocacy, community education, and public awareness. Highlights include:ambassador program - the Sick Cells ambassador program equips a diverse network of advocates with the tools and opportunities to represent and advance the scd community's interests. In 2025, we recruited 114 new ambassadors, growing the program to 432 individuals across 34 states and washington, dc. Program activities included 11 monthly advocacy workshops (priority topic meetings), and referrals to focus groups, research projects/surveys, and speaking engagements. Additionally, ambassadors…

    $965,517 spent$950,359 earned by the program
    100% of program spending

The program described on its FY2025 Form 990. Program spending in total: $965,517.

02The organization over time

The organization over time

Each line starts at 100 in 2020, so what you read is the shape rather than the size: 150 means half as much again as 2020, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20202020 Revenue 100 ($345k) Expenses 100 ($268k) Net assets 100 ($145k)2021 Revenue 191 ($658k) Expenses 150 ($403k) Net assets 275 ($400k)2022 Revenue 169 ($584k) Expenses 205 ($550k) Net assets 298 ($434k)2023 Revenue 264 ($910k) Expenses 281 ($755k) Net assets 405 ($589k)2024 Revenue 194 ($668k) Expenses 287 ($770k) Net assets 355 ($516k)2025 Revenue 309 ($1.1M) Expenses 485 ($1.3M) Net assets 193 ($280k)
202020212022202320242025
Revenue (309)Expenses (485)Net assets (193)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $145k to $400k (+175%).

$145k
$400k
$434k
$589k
$759k
$569k
202020212022202320242025
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2020 7% · 2021 3% · 2023 8%. Grants only. Government contracts and fees sit inside program revenue.

11% of SICK CELLS’s revenue is contributions — about as donation-reliant as the typical peer (51% for the typical peer).

This organization
Typical peer · 8,632 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 6 reported years ran a deficit.

$76k
’20
$255k
’21
$34k
’22
$155k
’23
−$102k
’24
−$236k
’25
4.6
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Ashley Valentine

Board chair

As listed on its FY2025 Form 990.

202020212022202320242025
Listed910111488
Joined·+1+1+3+0+0
No longer listed·00060
03Who funds it

Who funds it, year by year

2019 → 2023: the base narrowed from 2 funders to 1 funder, grant income fell $60k → $48.

2 of 5 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 9% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of SICK CELLS’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

SICK CELLS leans on a few funders — its largest provides 46% of grant income and the top three 96%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund SICK CELLS.

46%
largest funder
96%
top three
~3
effective funders

Largest funder’s share by year: 2019 83% · 2020 76% · 2021 75% · 2022 46% · 2023 100% — growing more concentrated.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

SICK CELLS draws 100% of its grant income from funders outside Illinois, across 1 state in all.

DC

In-state vs out-of-state, by year

’19
’20
’21
’22
Illinois out of state home

Funder states come from each funder’s own filing. $19k arriving through sponsors registered in 2 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

SICK CELLS has grown faster than three-quarters of the 5,002 health nonprofits its size.

Operating margin−22% · bottom quartile
Months of reserve4.6mo · above the median
Revenue growth (annualized)25% · top quartile

this organization peer median middle 50% of peers· 5,002 health nonprofits $1M–$10M, FY2025

Organizations like SICK CELLS

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Illinois

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

74% of spending goes to programs.

Program 74%Management 22%Fundraising 3%

Governance

7
board members
86%
independent
✓Conflict-of-interest policy–Whistleblower policy–Document retention✓Board reviewed the 990✓Audited financials

Public support

37%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 1 state

IL

Screen this organization

A dated, signed PDF of the compliance screen for SICK CELLS: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds SICK CELLS?
SICK CELLS (Illinois) receives grants from 5 organizations whose IRS filings report $206,520 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($95,500). 4 of them have funded it in more than one year.
How many funders does SICK CELLS have?
IRS filings report 5 organizations giving $206,520 in grants to SICK CELLS, 4 of which have funded it in more than one year.
Who is the largest funder of SICK CELLS?
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA is the largest funder on record, with $95,500 in grants. The full list of funders is on this page.
How can an organization like SICK CELLS find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Illinois. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Sick Cells →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2020–2025), and the filings of 5 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing